Analyst Says Sell Depomed As Challenging Opioid Environment Seen Persisting By: TalkMarkets August 08, 2017 at 13:17 PM EDT Shares of Depomed are plunging after the company reported weaker than expected second quarter results and lowered its guidance. Read More >> Related Stocks: Depomed Inc Endo Int'l Plc Insys Therapeutics Inc